| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/13/1996 | WO1996017948A1 Methods, compositions and apparatus for cell transfection |
| 06/13/1996 | WO1995034670A3 Recombinant aav genome encoding immunodeficiency virus protein |
| 06/13/1996 | CA2206600A1 Methods, compositions and apparatus for cell transfection |
| 06/12/1996 | EP0716148A2 Recombinant alphavirus vectors |
| 06/11/1996 | USRE35267 Separating agent, separator and method of separating cell or virus |
| 06/11/1996 | US5525715 Codes specific polypeptide; useful vaccine to immunize human infected from polio virus |
| 06/11/1996 | US5525342 Reovirus strain 2177 and vaccine containing same |
| 06/11/1996 | CA2164766A1 Process for the inactivation of viruses with the aid of acridine or acridine derivatives |
| 06/06/1996 | WO1996017072A2 Recombinant alphavirus vectors |
| 06/06/1996 | WO1996017070A1 Method of preparing a viral vector by homologous intermolecular recombination |
| 06/06/1996 | WO1996016676A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
| 06/06/1996 | WO1996016672A1 Serially passaged african green monkey kidney cells |
| 06/06/1996 | WO1996016538A1 A gonad-specific virus which causes sterility in the corn earworm, helicoverpa zea |
| 06/06/1996 | WO1995032298A3 Safe vectors for gene therapy |
| 06/06/1996 | CA2206205A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
| 06/06/1996 | CA2201585A1 Serially passaged african green monkey kidney cells |
| 06/05/1996 | EP0714436A1 Oligonucleotides with activity against human immunodeficiency virus |
| 06/05/1996 | EP0714307A1 Vaccine compositions |
| 06/05/1996 | EP0714306A1 Inactivated respiratory syncytial viral vaccines |
| 06/05/1996 | CN1124040A Adenoviral vectors of animal origin and use thereof in gene therapy |
| 06/04/1996 | US5523231 Method to isolate macromolecules using magnetically attractable beads which do not specifically bind the macromolecules |
| 05/30/1996 | WO1996016184A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems |
| 05/30/1996 | WO1996016164A1 Viral preparations, immunogens, and vaccines |
| 05/30/1996 | WO1996015798A2 Use of bioassimilable boron compounds for the control of subviral pathogenic agents |
| 05/30/1996 | WO1996015777A1 Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
| 05/30/1996 | CA2204252A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems |
| 05/29/1996 | EP0713915A1 Hog cholera virus vaccine and diagnostic |
| 05/29/1996 | EP0713397A1 Vaccine containing live virus for therapy of viral diseases and malignancies |
| 05/29/1996 | EP0431129B1 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 05/29/1996 | CN1123560A Biological control agents containing mollusc toxins |
| 05/28/1996 | US5521083 Large granular lymphocyte leukemia associated virus |
| 05/28/1996 | US5521082 Solvent extraction, precipitation, gel filtration, ion exchanging, vaccines |
| 05/23/1996 | WO1996015247A1 Purified papillomavirus proteins |
| 05/23/1996 | WO1996015232A1 Novel replication process |
| 05/23/1996 | WO1996015231A2 Method for producing biologicals in protein-free culture |
| 05/23/1996 | WO1996014737A1 Treating red blood cell solutions with anti-viral agents |
| 05/23/1996 | WO1996010580A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 05/23/1996 | CA2205410A1 Novel replication process |
| 05/22/1996 | EP0712926A2 Fish pancreatic disease virus |
| 05/21/1996 | US5518913 Genetic engineering |
| 05/21/1996 | US5518724 Infectious bursal disease virus |
| 05/17/1996 | WO1996014088A1 Attenuated canine parvovirus vaccine |
| 05/17/1996 | WO1996014077A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 05/17/1996 | WO1996014061A1 Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods |
| 05/17/1996 | WO1996010419A3 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 05/15/1996 | EP0711829A2 Recombinant alphavirus vectors |
| 05/15/1996 | EP0711340A1 High yielding influenza viruses |
| 05/15/1996 | CN1122613A Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 05/14/1996 | US5516629 Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins |
| 05/14/1996 | CA1338323C Retrovirus capable of causing aids, means and methods for detecting it in vitro |
| 05/09/1996 | WO1996013598A2 Hybrid adenovirus-aav virus and method of use thereof |
| 05/09/1996 | WO1996013597A2 Improved adenovirus and methods of use thereof |
| 05/09/1996 | WO1996013596A1 Viable contaminant particle free adenoviruses, their preparation and use |
| 05/09/1996 | WO1996013276A1 Ocular gene therapy |
| 05/09/1996 | WO1996007734A3 Recombinant adenovirus comprising a chimeric penton base protein |
| 05/09/1996 | CA2203374A1 Ocular gene therapy |
| 05/08/1996 | EP0710295A1 Htlv-ii nra? compositions and assays for detecting htlv infection |
| 05/08/1996 | EP0710280A1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 05/08/1996 | EP0710120A1 Recombinant swinepox virus |
| 05/08/1996 | CN1121959A Recombinant infectious non-segmented negative strand RNA virus |
| 05/07/1996 | US5514781 Use of azoles as virucidal agents in solutions of biologically active proteins |
| 05/07/1996 | US5514548 Method for in vivo selection of ligand-binding proteins |
| 05/07/1996 | US5514542 Methods for propagating retrovirus for use in antibody assays |
| 05/07/1996 | US5514376 Cell culture of hepatitis A virus |
| 05/02/1996 | WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 05/02/1996 | WO1996012790A1 Microbial synthesis of hiv protease inhibitors |
| 05/02/1996 | WO1996012492A1 Microbial synthesis of hiv protease inhibitors |
| 05/02/1996 | WO1996003997A3 Treatment of cancer using hsv mutant |
| 05/02/1996 | CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 04/30/1996 | US5512421 Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors |
| 04/25/1996 | WO1996012030A1 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 04/25/1996 | WO1996012028A1 Production of peptides in plants as viral coat protein fusions |
| 04/25/1996 | WO1996012027A1 Method of producing a chimeric protein |
| 04/25/1996 | WO1996012010A1 Preparation of rep-negative aav mutants and cells which can be used therefor |
| 04/25/1996 | WO1996011947A1 Materials for the production of nanometer structures and use thereof |
| 04/25/1996 | WO1996011706A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 04/25/1996 | CA2202761A1 Method of producing a chimeric protein |
| 04/25/1996 | CA2202664A1 Preparation of rep-negative aav mutants and cells which can be used therefor |
| 04/25/1996 | CA2202622A1 Use of protease inhibitors and protease vaccines to protect animals from flea infestation, and flea protease proteins, nucleic acid molecules and uses thereof |
| 04/25/1996 | CA2202474A1 Materials for the production of nanometer structures and use thereof |
| 04/25/1996 | CA2201399A1 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 04/24/1996 | EP0707652A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof |
| 04/24/1996 | EP0707644A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 04/24/1996 | EP0707636A1 Methods and compositions for the removal of viruses and uses thereof |
| 04/24/1996 | EP0707635A1 Direct and biochemically functional detection process of retrovirus in biological samples |
| 04/24/1996 | EP0707633A1 System for viral inactivation of blood |
| 04/23/1996 | US5510258 Porcine reproductive and respiratory syndrome virus antigen and processes for the preparation and use of said antigen in vaccines and diagnostics |
| 04/23/1996 | US5510106 Immunological response |
| 04/18/1996 | WO1996011280A1 Attenuated viruses and method of making the same |
| 04/18/1996 | WO1996011274A1 Chimeric papillomavirus-like particles |
| 04/18/1996 | WO1996011272A2 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 04/18/1996 | WO1996010997A1 Hepatitis virus vaccines |
| 04/18/1996 | CA2202088A1 Hepatitis virus vaccines |
| 04/18/1996 | CA2201487A1 Attenuated viruses and method of making the same |
| 04/17/1996 | EP0707068A1 Yeast vector |
| 04/17/1996 | EP0706569A1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
| 04/17/1996 | EP0706387A1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 04/17/1996 | EP0706319A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites |
| 04/17/1996 | EP0428596B1 Novel infectious bursal disease virus |
| 04/16/1996 | US5508187 In vitro phage lambda DNA packaging system |